English

SYNEOS HEALTH, INC.

EDGAR

SYNH Quarterly report (10-Q) · filed 2023-08-09

115 filing records in this dataset, filed from 2014-10-06 to 2023-08-09. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

1.37 billion USD

2023 Q2 · USD

Exact inputs and evidence

Revenue: 1366080000 USD Source

Operating margin

3.09%

2023 Q2 · %

Exact inputs and evidence

Operating Income: 42221000 USD Source
Revenue: 1366080000 USD Source

Operating cash flow

-33.7 million USD

2023 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -3258000 USD Source
Operating Cash Flow: 30424000 USD Source

Free cash flow

-51.6 million USD

2023 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -3258000 USD Source
Operating Cash Flow: 30424000 USD Source
Capital Expenditure: 45471000 USD Source
Capital Expenditure: 27509000 USD Source

Cash and cash equivalents: 154 million USD 2018-12-31 Source
Exact value

153863000 USD
Long-term debt including current maturities: 2.64 billion USD 2023-06-30 Source
Exact value

2641566000 USD
Shares outstanding: 103 million shares 2022-12-31 Source
Exact value

102911209 shares

Reported share-count change

-0.82% · -852 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

103763635 shares · 2021-12-31· Source
102911209 shares · 2022-12-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

5.42 billion USD

2022-07-01 – 2023-06-30

Exact inputs and evidence

Revenue: 1336223000 USD · 2022-07-01 – 2022-09-30 Source
Revenue: 5393082000 USD · 2022-01-01 – 2022-12-31 Source
Revenue: 4033215000 USD · 2022-01-01 – 2022-09-30 Source
Revenue: 1356800000 USD · 2023-01-01 – 2023-03-31 Source
Revenue: 1366080000 USD · 2023-04-01 – 2023-06-30 Source

Net income

71.2 million USD

2022-07-01 – 2023-06-30

Exact inputs and evidence

Net income: 87049000 USD · 2022-07-01 – 2022-09-30 Source
Net income: 266497000 USD · 2022-01-01 – 2022-12-31 Source
Net income: 210969000 USD · 2022-01-01 – 2022-09-30 Source
Net income: -72149000 USD · 2023-01-01 – 2023-03-31 Source
Net income: 793000 USD · 2023-04-01 – 2023-06-30 Source

Operating cash flow

253 million USD

2022-07-01 – 2023-06-30

Exact inputs and evidence

Operating cash flow: 303164000 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: 170789000 USD · 2022-01-01 – 2022-06-30 Source
Operating cash flow: 426981000 USD · 2022-01-01 – 2022-12-31 Source
Operating cash flow: 303164000 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: 30424000 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -3258000 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: 30424000 USD · 2023-01-01 – 2023-03-31 Source

Capital expenditure

91 million USD

2022-07-01 – 2023-06-30

Exact inputs and evidence

Capital expenditure: 69833000 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 47912000 USD · 2022-01-01 – 2022-06-30 Source
Capital expenditure: 93459000 USD · 2022-01-01 – 2022-12-31 Source
Capital expenditure: 69833000 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 27509000 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 45471000 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 27509000 USD · 2023-01-01 – 2023-03-31 Source

Free cash flow

162 million USD

2022-07-01 – 2023-06-30

Exact inputs and evidence

Operating cash flow: 303164000 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: 170789000 USD · 2022-01-01 – 2022-06-30 Source
Operating cash flow: 426981000 USD · 2022-01-01 – 2022-12-31 Source
Operating cash flow: 303164000 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: 30424000 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -3258000 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: 30424000 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 69833000 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 47912000 USD · 2022-01-01 – 2022-06-30 Source
Capital expenditure: 93459000 USD · 2022-01-01 – 2022-12-31 Source
Capital expenditure: 69833000 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 27509000 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 45471000 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 27509000 USD · 2023-01-01 – 2023-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2023-08-09.

Financial data available through: 2022-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2022-12-31
Operating income: 11 of 11 periods available· newest 2022-12-31
Net income: 11 of 11 periods available· newest 2022-12-31
Operating cash flow: 11 of 11 periods available· newest 2022-12-31
Capital expenditure: 11 of 11 periods available· newest 2022-12-31
Total assets: 10 of 11 periods available· newest 2022-12-31
Total liabilities: 10 of 11 periods available· newest 2022-12-31
Current assets: 10 of 11 periods available· newest 2022-12-31
Current liabilities: 10 of 11 periods available· newest 2022-12-31
Cash and cash equivalents: 7 of 11 periods available· newest 2018-12-31
Long-term debt including current maturities: 9 of 11 periods available· newest 2022-12-31
Shares outstanding: 10 of 11 periods available· newest 2022-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+3.5%

Prior period

USD 5.21 billion

2021-01-01 – 2021-12-31
Current period

USD 5.39 billion

2022-01-01 – 2022-12-31

Exact inputs and evidence

5393082000 − 5212970000 = 180112000 USD

5212970000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
5393082000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · SYNEOS HEALTH, INC. · 2022-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Year-over-year change in Revenue: 180112000 USD Concept: fundies:Revenue Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 5393082000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000095017023002928/synh-20221231.htm#5222364 Filing: 000095017023002928 Input fundies:Revenue: 5212970000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000095017023002928/synh-20221231.htm#5224530 Filing: 000095017023002928
The citation records this snapshot. The page link may show a newer release later.
Net income
+13.5%

Prior period

USD 234.83 million

2021-01-01 – 2021-12-31
Current period

USD 266.5 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

266497000 − 234831000 = 31666000 USD

234831000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
266497000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · SYNEOS HEALTH, INC. · 2022-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Year-over-year change in Net income: 31666000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 266497000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000095017023002928/synh-20221231.htm#4487741 Filing: 000095017023002928 Input fundies:NetIncome: 234831000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000095017023002928/synh-20221231.htm#4489877 Filing: 000095017023002928
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-5.2%

Prior period

USD 450.28 million

2021-01-01 – 2021-12-31
Current period

USD 426.98 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

426981000 − 450278000 = -23297000 USD

450278000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
426981000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · SYNEOS HEALTH, INC. · 2022-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Year-over-year change in Operating cash flow: -23297000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 426981000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000095017023002928/synh-20221231.htm#2393163 Filing: 000095017023002928 Input fundies:OperatingCashFlow: 450278000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000095017023002928/synh-20221231.htm#2395078 Filing: 000095017023002928
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+64.4%

Prior period

USD 56.84 million

2021-01-01 – 2021-12-31
Current period

USD 93.46 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

93459000 − 56841000 = 36618000 USD

56841000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
93459000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · SYNEOS HEALTH, INC. · 2022-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Year-over-year change in Capital expenditure: 36618000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 93459000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000095017023002928/synh-20221231.htm#2423348 Filing: 000095017023002928 Input fundies:CapitalExpenditure: 56841000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000095017023002928/synh-20221231.htm#2425521 Filing: 000095017023002928
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2022 2022-01-01 – 2022-12-31

Revenue USD 5.39 billion 100% of revenue
Operating costs Derived USD 4.99 billion 93% of revenue
Operating income USD 403.19 million 7.5% of revenue
Tax, interest and other Derived USD 136.7 million 2.5% of revenue
Net income USD 266.5 million 4.9% of revenue

Cash

Operating cash flow USD 426.98 million 7.9% of revenue
Capital expenditure USD 93.46 million 1.7% of revenue
Free cash flow Derived USD 333.52 million 6.2% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2014 Net loss: net income was −2% of revenue.
2015 89%
2016 90%
2017 Operating loss: operating costs were 101% of revenue.
2018 96%
2019 95%
2020 93%
2021 93%
2022 93%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2014 2014-01-01 – 2014-12-31	1178799000	1115155000 Derived	63644000	87114000 Derived	-23470000	105896000 Derived	Source 2014-01-01 – 2014-12-31: 1178799000 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: 63644000 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: -23470000 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: 131447000 USD Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 25551000 USD Inspect Capital Expenditure Open source
2015 2015-01-01 – 2015-12-31	1399239000	1246879000 Derived	152360000	35313000 Derived	117047000	183629000 Derived	Source 2015-01-01 – 2015-12-31: 1399239000 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: 152360000 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: 117047000 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: 204740000 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 21111000 USD Inspect Capital Expenditure Open source
2016 2016-01-01 – 2016-12-31	1610596000	1455237000 Derived	155359000	42729000 Derived	112630000	78137000 Derived	Source 2016-01-01 – 2016-12-31: 1610596000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: 155359000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: 112630000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: 109490000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 31353000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	2672064000	2700930000 Derived	-28866000	109603000 Derived	-138469000	154362000 Derived	Source 2017-01-01 – 2017-12-31: 2672064000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -28866000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -138469000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: 198258000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 43896000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	4390116000	4229934000 Derived	160182000	135898000 Derived	24284000	248853000 Derived	Source 2018-01-01 – 2018-12-31: 4390116000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: 160182000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: 24284000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: 303448000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 54595000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	4675815000	4438061000 Derived	237754000	106496000 Derived	131258000	254508000 Derived	Source 2019-01-01 – 2019-12-31: 4675815000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: 237754000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: 131258000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: 318481000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 63973000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	4415777000	4122634000 Derived	293143000	100356000 Derived	192787000	375483000 Derived	Source 2020-01-01 – 2020-12-31: 4415777000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: 293143000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: 192787000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: 425493000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 50010000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	5212970000	4823690000 Derived	389280000	154449000 Derived	234831000	393437000 Derived	Source 2021-01-01 – 2021-12-31: 5212970000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: 389280000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: 234831000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: 450278000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 56841000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	5393082000	4989890000 Derived	403192000	136695000 Derived	266497000	333522000 Derived	Source 2022-01-01 – 2022-12-31: 5393082000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: 403192000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: 266497000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: 426981000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 93459000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 5.4B 2022

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20132013-12-31	Revenue	995090000	Revenue: 995090000 Open source
20142014-12-31	Revenue	1178799000	Revenue: 1178799000 Open source
20152015-12-31	Revenue	1399239000	Revenue: 1399239000 Open source
20162016-12-31	Revenue	1610596000	Revenue: 1610596000 Open source
20172017-12-31	Revenue	2672064000	Revenue: 2672064000 Open source
20182018-12-31	Revenue	4390116000	Revenue: 4390116000 Open source
20192019-12-31	Revenue	4675815000	Revenue: 4675815000 Open source
20202020-12-31	Revenue	4415777000	Revenue: 4415777000 Open source
20212021-12-31	Revenue	5212970000	Revenue: 5212970000 Open source
20222022-12-31	Revenue	5393082000	Revenue: 5393082000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

3.5% 2022

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20132013-12-31	Year over year	14.6%	Revenue: 995090000 Open source Revenue: 868600000 Open source
20142014-12-31	Year over year	18.5%	Revenue: 1178799000 Open source Revenue: 995090000 Open source
20152015-12-31	Year over year	18.7%	Revenue: 1399239000 Open source Revenue: 1178799000 Open source
20162016-12-31	Year over year	15.1%	Revenue: 1610596000 Open source Revenue: 1399239000 Open source
20172017-12-31	Year over year	65.9%	Revenue: 2672064000 Open source Revenue: 1610596000 Open source
20182018-12-31	Year over year	64.3%	Revenue: 4390116000 Open source Revenue: 2672064000 Open source
20192019-12-31	Year over year	6.5%	Revenue: 4675815000 Open source Revenue: 4390116000 Open source
20202020-12-31	Year over year	-5.6%	Revenue: 4415777000 Open source Revenue: 4675815000 Open source
20212021-12-31	Year over year	18.1%	Revenue: 5212970000 Open source Revenue: 4415777000 Open source
20222022-12-31	Year over year	3.5%	Revenue: 5393082000 Open source Revenue: 5212970000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 7.5% 2022

Net margin 4.9% 2022

Free cash flow margin 6.2% 2022

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20132013-12-31	Operating margin	3.2%	Operating Income: 31458000 Open source Revenue: 995090000 Open source
20142014-12-31	Operating margin	5.4%	Operating Income: 63644000 Open source Revenue: 1178799000 Open source
20152015-12-31	Operating margin	10.9%	Operating Income: 152360000 Open source Revenue: 1399239000 Open source
20162016-12-31	Operating margin	9.6%	Operating Income: 155359000 Open source Revenue: 1610596000 Open source
20172017-12-31	Operating margin	-1.1%	Operating Income: -28866000 Open source Revenue: 2672064000 Open source
20182018-12-31	Operating margin	3.6%	Operating Income: 160182000 Open source Revenue: 4390116000 Open source
20192019-12-31	Operating margin	5.1%	Operating Income: 237754000 Open source Revenue: 4675815000 Open source
20202020-12-31	Operating margin	6.6%	Operating Income: 293143000 Open source Revenue: 4415777000 Open source
20212021-12-31	Operating margin	7.5%	Operating Income: 389280000 Open source Revenue: 5212970000 Open source
20222022-12-31	Operating margin	7.5%	Operating Income: 403192000 Open source Revenue: 5393082000 Open source
20132013-12-31	Net margin	-4.2%	Net Income: -41529000 Open source Revenue: 995090000 Open source
20142014-12-31	Net margin	-2%	Net Income: -23470000 Open source Revenue: 1178799000 Open source
20152015-12-31	Net margin	8.4%	Net Income: 117047000 Open source Revenue: 1399239000 Open source
2016-12-31	Net margin	Not reported	Revenue: 1610596000 Open source
20172017-12-31	Net margin	-5.2%	Net Income: -138469000 Open source Revenue: 2672064000 Open source
20182018-12-31	Net margin	0.6%	Net Income: 24284000 Open source Revenue: 4390116000 Open source
20192019-12-31	Net margin	2.8%	Net Income: 131258000 Open source Revenue: 4675815000 Open source
20202020-12-31	Net margin	4.4%	Net Income: 192787000 Open source Revenue: 4415777000 Open source
20212021-12-31	Net margin	4.5%	Net Income: 234831000 Open source Revenue: 5212970000 Open source
20222022-12-31	Net margin	4.9%	Net Income: 266497000 Open source Revenue: 5393082000 Open source
20132013-12-31	Free cash flow margin	Not reported	Revenue: 995090000 Open source
20142014-12-31	Free cash flow margin	9%	Revenue: 1178799000 Open source Operating Cash Flow: 131447000 Open source Capital Expenditure: 25551000 Open source
20152015-12-31	Free cash flow margin	13.1%	Revenue: 1399239000 Open source Operating Cash Flow: 204740000 Open source Capital Expenditure: 21111000 Open source
20162016-12-31	Free cash flow margin	4.9%	Revenue: 1610596000 Open source Operating Cash Flow: 109490000 Open source Capital Expenditure: 31353000 Open source
20172017-12-31	Free cash flow margin	5.8%	Revenue: 2672064000 Open source Operating Cash Flow: 198258000 Open source Capital Expenditure: 43896000 Open source
20182018-12-31	Free cash flow margin	5.7%	Revenue: 4390116000 Open source Operating Cash Flow: 303448000 Open source Capital Expenditure: 54595000 Open source
20192019-12-31	Free cash flow margin	5.4%	Revenue: 4675815000 Open source Operating Cash Flow: 318481000 Open source Capital Expenditure: 63973000 Open source
20202020-12-31	Free cash flow margin	8.5%	Revenue: 4415777000 Open source Operating Cash Flow: 425493000 Open source Capital Expenditure: 50010000 Open source
20212021-12-31	Free cash flow margin	7.5%	Revenue: 5212970000 Open source Operating Cash Flow: 450278000 Open source Capital Expenditure: 56841000 Open source
20222022-12-31	Free cash flow margin	6.2%	Revenue: 5393082000 Open source Operating Cash Flow: 426981000 Open source Capital Expenditure: 93459000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 427M 2022

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20132013-12-31	Operating cash flow	Not reported	No source recorded
20142014-12-31	Operating cash flow	131447000	Operating Cash Flow: 131447000 Open source
20152015-12-31	Operating cash flow	204740000	Operating Cash Flow: 204740000 Open source
20162016-12-31	Operating cash flow	109490000	Operating Cash Flow: 109490000 Open source
20172017-12-31	Operating cash flow	198258000	Operating Cash Flow: 198258000 Open source
20182018-12-31	Operating cash flow	303448000	Operating Cash Flow: 303448000 Open source
20192019-12-31	Operating cash flow	318481000	Operating Cash Flow: 318481000 Open source
20202020-12-31	Operating cash flow	425493000	Operating Cash Flow: 425493000 Open source
20212021-12-31	Operating cash flow	450278000	Operating Cash Flow: 450278000 Open source
20222022-12-31	Operating cash flow	426981000	Operating Cash Flow: 426981000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 333.5M 2022

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20132013-12-31	Free cash flow	Unavailable	No source recorded
20142014-12-31	Free cash flow	105896000	Operating Cash Flow: 131447000 Open source Capital Expenditure: 25551000 Open source
20152015-12-31	Free cash flow	183629000	Operating Cash Flow: 204740000 Open source Capital Expenditure: 21111000 Open source
20162016-12-31	Free cash flow	78137000	Operating Cash Flow: 109490000 Open source Capital Expenditure: 31353000 Open source
20172017-12-31	Free cash flow	154362000	Operating Cash Flow: 198258000 Open source Capital Expenditure: 43896000 Open source
20182018-12-31	Free cash flow	248853000	Operating Cash Flow: 303448000 Open source Capital Expenditure: 54595000 Open source
20192019-12-31	Free cash flow	254508000	Operating Cash Flow: 318481000 Open source Capital Expenditure: 63973000 Open source
20202020-12-31	Free cash flow	375483000	Operating Cash Flow: 425493000 Open source Capital Expenditure: 50010000 Open source
20212021-12-31	Free cash flow	393437000	Operating Cash Flow: 450278000 Open source Capital Expenditure: 56841000 Open source
20222022-12-31	Free cash flow	333522000	Operating Cash Flow: 426981000 Open source Capital Expenditure: 93459000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

57.4% 2022

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20132013-12-31	Liabilities / assets	77.6%	Total Liabilities: 956904000 Open source Total Assets: 1233111000 Open source
20142014-12-31	Liabilities / assets	68.4%	Total Liabilities: 849156000 Open source Total Assets: 1241365000 Open source
20152015-12-31	Liabilities / assets	82%	Total Liabilities: 993785000 Open source Total Assets: 1211219000 Open source
20162016-12-31	Liabilities / assets	76.6%	Total Liabilities: 987034000 Open source Total Assets: 1288507000 Open source
20172017-12-31	Liabilities / assets	58.5%	Total Liabilities: 4263288000 Open source Total Assets: 7285867000 Open source
20182018-12-31	Liabilities / assets	60.6%	Total Liabilities: 4398765000 Open source Total Assets: 7254909000 Open source
20192019-12-31	Liabilities / assets	59.4%	Total Liabilities: 4424141000 Open source Total Assets: 7453795000 Open source
20202020-12-31	Liabilities / assets	59.8%	Total Liabilities: 4821194000 Open source Total Assets: 8063306000 Open source
20212021-12-31	Liabilities / assets	58.6%	Total Liabilities: 4824538000 Open source Total Assets: 8237093000 Open source
20222022-12-31	Liabilities / assets	57.4%	Total Liabilities: 4704217000 Open source Total Assets: 8199218000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.13× 2022

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20132013-12-31	Current assets / current liabilities	1.18×	Current Assets: 376182000 Open source Current Liabilities: 318008000 Open source
20142014-12-31	Current assets / current liabilities	1.12×	Current Assets: 426264000 Open source Current Liabilities: 379172000 Open source
20152015-12-31	Current assets / current liabilities	0.89×	Current Assets: 422046000 Open source Current Liabilities: 474592000 Open source
20162016-12-31	Current assets / current liabilities	1.12×	Current Assets: 522629000 Open source Current Liabilities: 466727000 Open source
20172017-12-31	Current assets / current liabilities	1.23×	Current Assets: 1422179000 Open source Current Liabilities: 1159562000 Open source
20182018-12-31	Current assets / current liabilities	0.99×	Current Assets: 1491962000 Open source Current Liabilities: 1503198000 Open source
20192019-12-31	Current assets / current liabilities	1.03×	Current Assets: 1562164000 Open source Current Liabilities: 1516461000 Open source
20202020-12-31	Current assets / current liabilities	1.1×	Current Assets: 1738012000 Open source Current Liabilities: 1577331000 Open source
20212021-12-31	Current assets / current liabilities	1.07×	Current Assets: 1766456000 Open source Current Liabilities: 1654116000 Open source
20222022-12-31	Current assets / current liabilities	1.13×	Current Assets: 1943936000 Open source Current Liabilities: 1724691000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2014 2014-01-01 – 2014-12-31	−USD 23.47 million Exact value Exact value: -23470000 USD 2014-01-01 – 2014-12-31: -23470000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SYNEOS HEALTH, INC. · 2014-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Net Income: -23470000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -23470000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000161095017000005/incr-20161231.xml#332798 Filing: 000161095017000005 The citation records this snapshot. The page link may show a newer release later.	USD 131.45 million Exact value Exact value: 131447000 USD 2014-01-01 – 2014-12-31: 131447000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SYNEOS HEALTH, INC. · 2014-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Operating Cash Flow: 131447000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 131447000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000161095017000005/incr-20161231.xml#331775 Filing: 000161095017000005 The citation records this snapshot. The page link may show a newer release later.	USD 25.55 million Exact value Exact value: 25551000 USD 2014-01-01 – 2014-12-31: 25551000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SYNEOS HEALTH, INC. · 2014-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Capital Expenditure: 25551000 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 25551000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000161095017000005/incr-20161231.xml#362909 Filing: 000161095017000005 The citation records this snapshot. The page link may show a newer release later.	USD 105.9 million Calculation and evidence 131447000 − 25551000 USD Exact free cash flow: 105896000 USD 2014-01-01 – 2014-12-31: 131447000 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 25551000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SYNEOS HEALTH, INC. · 2014-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Free cash flow: 105896000 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 131447000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000161095017000005/incr-20161231.xml#331775 Filing: 000161095017000005 Input fundies:CapitalExpenditure: 25551000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000161095017000005/incr-20161231.xml#362909 Filing: 000161095017000005 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	USD 117.05 million Exact value Exact value: 117047000 USD 2015-01-01 – 2015-12-31: 117047000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SYNEOS HEALTH, INC. · 2015-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Net Income: 117047000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: 117047000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000161095018000006/synh-20171231.xml#535121 Filing: 000161095018000006 The citation records this snapshot. The page link may show a newer release later.	USD 204.74 million Exact value Exact value: 204740000 USD 2015-01-01 – 2015-12-31: 204740000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SYNEOS HEALTH, INC. · 2015-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Operating Cash Flow: 204740000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 204740000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000161095018000006/synh-20171231.xml#534485 Filing: 000161095018000006 The citation records this snapshot. The page link may show a newer release later.	USD 21.11 million Exact value Exact value: 21111000 USD 2015-01-01 – 2015-12-31: 21111000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SYNEOS HEALTH, INC. · 2015-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Capital Expenditure: 21111000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 21111000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000161095018000006/synh-20171231.xml#574646 Filing: 000161095018000006 The citation records this snapshot. The page link may show a newer release later.	USD 183.63 million Calculation and evidence 204740000 − 21111000 USD Exact free cash flow: 183629000 USD 2015-01-01 – 2015-12-31: 204740000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 21111000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SYNEOS HEALTH, INC. · 2015-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Free cash flow: 183629000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 204740000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000161095018000006/synh-20171231.xml#534485 Filing: 000161095018000006 Input fundies:CapitalExpenditure: 21111000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000161095018000006/synh-20171231.xml#574646 Filing: 000161095018000006 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	USD 112.63 million Exact value Exact value: 112630000 USD 2016-01-01 – 2016-12-31: 112630000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SYNEOS HEALTH, INC. · 2016-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Net Income: 112630000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: 112630000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000161095019000008/synh-20181231.xml#610814 Filing: 000161095019000008 The citation records this snapshot. The page link may show a newer release later.	USD 109.49 million Exact value Exact value: 109490000 USD 2016-01-01 – 2016-12-31: 109490000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SYNEOS HEALTH, INC. · 2016-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Operating Cash Flow: 109490000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 109490000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000161095019000008/synh-20181231.xml#610178 Filing: 000161095019000008 The citation records this snapshot. The page link may show a newer release later.	USD 31.35 million Exact value Exact value: 31353000 USD 2016-01-01 – 2016-12-31: 31353000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SYNEOS HEALTH, INC. · 2016-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Capital Expenditure: 31353000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 31353000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000161095019000008/synh-20181231.xml#654355 Filing: 000161095019000008 The citation records this snapshot. The page link may show a newer release later.	USD 78.14 million Calculation and evidence 109490000 − 31353000 USD Exact free cash flow: 78137000 USD 2016-01-01 – 2016-12-31: 109490000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 31353000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SYNEOS HEALTH, INC. · 2016-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Free cash flow: 78137000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 109490000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000161095019000008/synh-20181231.xml#610178 Filing: 000161095019000008 Input fundies:CapitalExpenditure: 31353000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000161095019000008/synh-20181231.xml#654355 Filing: 000161095019000008 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-02 – 2016-12-31	USD 112.63 million Exact value Exact value: 112630000 USD 2016-01-02 – 2016-12-31: 112630000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SYNEOS HEALTH, INC. · 2016-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Net Income: 112630000 USD Concept: fundies:NetIncome Period: 2016-01-02 to 2016-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-02&unit=USD&dimensions= Input fundies:NetIncome: 112630000 USD (2016-01-02 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000161095017000005/incr-20161231.xml#332411 Filing: 000161095017000005 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2017 2017-01-01 – 2017-12-31	−USD 138.47 million Exact value Exact value: -138469000 USD 2017-01-01 – 2017-12-31: -138469000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SYNEOS HEALTH, INC. · 2017-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Net Income: -138469000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -138469000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000161095020000043/synh-20191231.htm#3621984 Filing: 000161095020000043 The citation records this snapshot. The page link may show a newer release later.	USD 198.26 million Exact value Exact value: 198258000 USD 2017-01-01 – 2017-12-31: 198258000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SYNEOS HEALTH, INC. · 2017-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Operating Cash Flow: 198258000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 198258000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000161095020000043/synh-20191231.htm#1993200 Filing: 000161095020000043 The citation records this snapshot. The page link may show a newer release later.	USD 43.9 million Exact value Exact value: 43896000 USD 2017-01-01 – 2017-12-31: 43896000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SYNEOS HEALTH, INC. · 2017-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Capital Expenditure: 43896000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 43896000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000161095020000043/synh-20191231.htm#2002891 Filing: 000161095020000043 The citation records this snapshot. The page link may show a newer release later.	USD 154.36 million Calculation and evidence 198258000 − 43896000 USD Exact free cash flow: 154362000 USD 2017-01-01 – 2017-12-31: 198258000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 43896000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SYNEOS HEALTH, INC. · 2017-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Free cash flow: 154362000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 198258000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000161095020000043/synh-20191231.htm#1993200 Filing: 000161095020000043 Input fundies:CapitalExpenditure: 43896000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000161095020000043/synh-20191231.htm#2002891 Filing: 000161095020000043 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	USD 24.28 million Exact value Exact value: 24284000 USD 2018-01-01 – 2018-12-31: 24284000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SYNEOS HEALTH, INC. · 2018-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Net Income: 24284000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: 24284000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000156459021006471/synh-10k_20201231.htm#4550522 Filing: 000156459021006471 The citation records this snapshot. The page link may show a newer release later.	USD 303.45 million Exact value Exact value: 303448000 USD 2018-01-01 – 2018-12-31: 303448000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SYNEOS HEALTH, INC. · 2018-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Operating Cash Flow: 303448000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 303448000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000156459021006471/synh-10k_20201231.htm#2499953 Filing: 000156459021006471 The citation records this snapshot. The page link may show a newer release later.	USD 54.6 million Exact value Exact value: 54595000 USD 2018-01-01 – 2018-12-31: 54595000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SYNEOS HEALTH, INC. · 2018-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Capital Expenditure: 54595000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 54595000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000156459021006471/synh-10k_20201231.htm#2521497 Filing: 000156459021006471 The citation records this snapshot. The page link may show a newer release later.	USD 248.85 million Calculation and evidence 303448000 − 54595000 USD Exact free cash flow: 248853000 USD 2018-01-01 – 2018-12-31: 303448000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 54595000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SYNEOS HEALTH, INC. · 2018-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Free cash flow: 248853000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 303448000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000156459021006471/synh-10k_20201231.htm#2499953 Filing: 000156459021006471 Input fundies:CapitalExpenditure: 54595000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000156459021006471/synh-10k_20201231.htm#2521497 Filing: 000156459021006471 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	USD 131.26 million Exact value Exact value: 131258000 USD 2019-01-01 – 2019-12-31: 131258000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SYNEOS HEALTH, INC. · 2019-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Net Income: 131258000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: 131258000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000156459022005428/synh-10k_20211231.htm#4393010 Filing: 000156459022005428 The citation records this snapshot. The page link may show a newer release later.	USD 318.48 million Exact value Exact value: 318481000 USD 2019-01-01 – 2019-12-31: 318481000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SYNEOS HEALTH, INC. · 2019-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Operating Cash Flow: 318481000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 318481000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000156459022005428/synh-10k_20211231.htm#2364568 Filing: 000156459022005428 The citation records this snapshot. The page link may show a newer release later.	USD 63.97 million Exact value Exact value: 63973000 USD 2019-01-01 – 2019-12-31: 63973000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SYNEOS HEALTH, INC. · 2019-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Capital Expenditure: 63973000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 63973000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000156459022005428/synh-10k_20211231.htm#2391333 Filing: 000156459022005428 The citation records this snapshot. The page link may show a newer release later.	USD 254.51 million Calculation and evidence 318481000 − 63973000 USD Exact free cash flow: 254508000 USD 2019-01-01 – 2019-12-31: 318481000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 63973000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SYNEOS HEALTH, INC. · 2019-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Free cash flow: 254508000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 318481000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000156459022005428/synh-10k_20211231.htm#2364568 Filing: 000156459022005428 Input fundies:CapitalExpenditure: 63973000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000156459022005428/synh-10k_20211231.htm#2391333 Filing: 000156459022005428 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	USD 192.79 million Exact value Exact value: 192787000 USD 2020-01-01 – 2020-12-31: 192787000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SYNEOS HEALTH, INC. · 2020-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Net Income: 192787000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: 192787000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000095017023002928/synh-20221231.htm#4492013 Filing: 000095017023002928 The citation records this snapshot. The page link may show a newer release later.	USD 425.49 million Exact value Exact value: 425493000 USD 2020-01-01 – 2020-12-31: 425493000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SYNEOS HEALTH, INC. · 2020-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Operating Cash Flow: 425493000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 425493000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000095017023002928/synh-20221231.htm#2396993 Filing: 000095017023002928 The citation records this snapshot. The page link may show a newer release later.	USD 50.01 million Exact value Exact value: 50010000 USD 2020-01-01 – 2020-12-31: 50010000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SYNEOS HEALTH, INC. · 2020-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Capital Expenditure: 50010000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 50010000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000095017023002928/synh-20221231.htm#2427694 Filing: 000095017023002928 The citation records this snapshot. The page link may show a newer release later.	USD 375.48 million Calculation and evidence 425493000 − 50010000 USD Exact free cash flow: 375483000 USD 2020-01-01 – 2020-12-31: 425493000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 50010000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SYNEOS HEALTH, INC. · 2020-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Free cash flow: 375483000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 425493000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000095017023002928/synh-20221231.htm#2396993 Filing: 000095017023002928 Input fundies:CapitalExpenditure: 50010000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000095017023002928/synh-20221231.htm#2427694 Filing: 000095017023002928 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	USD 234.83 million Exact value Exact value: 234831000 USD 2021-01-01 – 2021-12-31: 234831000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SYNEOS HEALTH, INC. · 2021-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Net Income: 234831000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: 234831000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000095017023002928/synh-20221231.htm#4489877 Filing: 000095017023002928 The citation records this snapshot. The page link may show a newer release later.	USD 450.28 million Exact value Exact value: 450278000 USD 2021-01-01 – 2021-12-31: 450278000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SYNEOS HEALTH, INC. · 2021-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Operating Cash Flow: 450278000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 450278000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000095017023002928/synh-20221231.htm#2395078 Filing: 000095017023002928 The citation records this snapshot. The page link may show a newer release later.	USD 56.84 million Exact value Exact value: 56841000 USD 2021-01-01 – 2021-12-31: 56841000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SYNEOS HEALTH, INC. · 2021-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Capital Expenditure: 56841000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 56841000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000095017023002928/synh-20221231.htm#2425521 Filing: 000095017023002928 The citation records this snapshot. The page link may show a newer release later.	USD 393.44 million Calculation and evidence 450278000 − 56841000 USD Exact free cash flow: 393437000 USD 2021-01-01 – 2021-12-31: 450278000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 56841000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SYNEOS HEALTH, INC. · 2021-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Free cash flow: 393437000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 450278000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000095017023002928/synh-20221231.htm#2395078 Filing: 000095017023002928 Input fundies:CapitalExpenditure: 56841000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000095017023002928/synh-20221231.htm#2425521 Filing: 000095017023002928 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	USD 266.5 million Exact value Exact value: 266497000 USD 2022-01-01 – 2022-12-31: 266497000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SYNEOS HEALTH, INC. · 2022-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Net Income: 266497000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: 266497000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000095017023002928/synh-20221231.htm#4487741 Filing: 000095017023002928 The citation records this snapshot. The page link may show a newer release later.	USD 426.98 million Exact value Exact value: 426981000 USD 2022-01-01 – 2022-12-31: 426981000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SYNEOS HEALTH, INC. · 2022-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Operating Cash Flow: 426981000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 426981000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000095017023002928/synh-20221231.htm#2393163 Filing: 000095017023002928 The citation records this snapshot. The page link may show a newer release later.	USD 93.46 million Exact value Exact value: 93459000 USD 2022-01-01 – 2022-12-31: 93459000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SYNEOS HEALTH, INC. · 2022-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Capital Expenditure: 93459000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 93459000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000095017023002928/synh-20221231.htm#2423348 Filing: 000095017023002928 The citation records this snapshot. The page link may show a newer release later.	USD 333.52 million Calculation and evidence 426981000 − 93459000 USD Exact free cash flow: 333522000 USD 2022-01-01 – 2022-12-31: 426981000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 93459000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SYNEOS HEALTH, INC. · 2022-12-31 SYNEOS HEALTH, INC. (edgar:1610950) Free cash flow: 333522000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: b31d7048d1fb3d5944c392b7d63067fa13f729844aa959fbbce021189ef64041 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1610950?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 426981000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000095017023002928/synh-20221231.htm#2393163 Filing: 000095017023002928 Input fundies:CapitalExpenditure: 93459000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1610950/000095017023002928/synh-20221231.htm#2423348 Filing: 000095017023002928 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

115 filings · 3,940 latest values · 3,940 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001610950, 1610950, SYNH, edgar:1610950

Also known as INC Research Holdings, Inc., SYNEOS HEALTH, INC., Syneos Health, Inc.

SYNEOS HEALTH, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2022 2022-01-01 – 2022-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation